TOBAM’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.42M | Buy |
20,195
+6,040
| +43% | +$1.32M | 1.72% | 19 |
|
|
2025
Q1 | $3.17M | Buy |
14,155
+9,642
| +214% | +$2.16M | 1.35% | 23 |
|
|
2024
Q4 | $1.48M | Buy |
4,513
+813
| +22% | +$266K | 0.45% | 68 |
|
|
2024
Q3 | $1.11M | Buy |
3,700
+2,423
| +190% | +$728K | 0.2% | 87 |
|
|
2024
Q2 | $421K | Sell |
1,277
-9,429
| -88% | -$3.11M | 0.07% | 121 |
|
|
2024
Q1 | $4.24M | Buy |
10,706
+10,295
| +2,505% | +$4.07M | 0.38% | 57 |
|
|
2023
Q4 | $145K | Sell |
411
-166
| -29% | -$58.6K | 0.01% | 256 |
|
|
2023
Q3 | $216K | Buy |
577
+86
| +18% | +$32.2K | 0.02% | 210 |
|
|
2023
Q2 | $188K | Hold |
491
| – | – | 0.01% | 252 |
|
|
2023
Q1 | $170K | Buy |
491
+97
| +25% | +$33.6K | 0.01% | 246 |
|
|
2022
Q4 | $93K | Hold |
394
| – | – | 0.01% | 310 |
|
|
2022
Q3 | $97K | Hold |
394
| – | – | 0.01% | 285 |
|
|
2022
Q2 | $119K | Sell |
394
-87
| -18% | -$26.3K | 0.01% | 292 |
|
|
2022
Q1 | $198K | Buy |
481
+230
| +92% | +$94.7K | 0.01% | 234 |
|
|
2021
Q4 | $118K | Hold |
251
| – | – | 0.01% | 247 |
|
|
2021
Q3 | $107K | Hold |
251
| – | – | ﹤0.01% | 257 |
|
|
2021
Q2 | $90K | Hold |
251
| – | – | ﹤0.01% | 274 |
|
|
2021
Q1 | $71K | Hold |
251
| – | – | ﹤0.01% | 289 |
|
|
2020
Q4 | $71K | Hold |
251
| – | – | ﹤0.01% | 275 |
|
|
2020
Q3 | $69K | Buy |
+251
| New | +$69K | ﹤0.01% | 261 |
|